Cargando…

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States

BACKGROUND: Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) substantially reduces the risk of HIV acquisition, yet significant barriers exist to its prescription and use. Incorporating pharmacists in the PrEP care process may help increase access to PrEP services. METHODS: Our pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Havens, Joshua P, Scarsi, Kimberly K, Sayles, Harlan, Klepser, Donald G, Swindells, Susan, Bares, Sara H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765348/ https://www.ncbi.nlm.nih.gov/pubmed/31412131 http://dx.doi.org/10.1093/ofid/ofz365

Ejemplares similares

1294. Acceptability and Feasibility of a Pharmacist-led Pre-exposure Prophylaxis Program in the Midwestern United States
por: Bares, Sara, et al.
Publicado: (2018)

Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV
por: Broekhuis, Jordan M., et al.
Publicado: (2018)

US Human Immunodeficiency Virus (HIV) Practitioners’ Recommendations Regarding Condomless Sex in the Era of HIV Pre-Exposure Prophylaxis and Treatment as Prevention
por: Schreier, Travis, et al.
Publicado: (2019)

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction
por: Lee, Sarah S., et al.
Publicado: (2018)

Response to Dong et al.
por: Havens, Joshua P, et al.
Publicado: (2020)

Acceptability, Feasibility, and Appropriateness of Implementation of Long-acting Injectable Antiretrovirals: A National Survey of Ryan White Clinics in the United States
por: Tarfa, Adati, et al.
Publicado: (2023)

Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States
por: Dong, Betty J, et al.
Publicado: (2019)

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study
por: Havens, Joshua P, et al.
Publicado: (2023)

Impact of Pharmacy Type on HIV Viral Suppression: A Retrospective Cross-Sectional Cohort Study
por: Havens, Joshua P, et al.
Publicado: (2020)

Surprisingly Low Levels of Measles Immunity in Persons With HIV: A Seroprevalence Survey in a United States HIV Clinic
por: Rearigh, Lindsey, et al.
Publicado: (2020)

1557 Impact of HIV Pharmacist Reconcilation on Correction of Antiretroviral Prescription Errors Among Hospitalized HIV-Infected Patients
por: Batra, Rishi, et al.
Publicado: (2014)

942. Lung Cancer Screening in at-risk patients with HIV in a Midwestern Clinic
por: Lopez, Wilfredo, et al.
Publicado: (2020)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Selvaraj, Shailendra V, et al.
Publicado: (2020)

Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: MacDonald, Calum B., et al.
Publicado: (2023)

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention
por: Glaubius, Robert L., et al.
Publicado: (2016)

Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Fulcher, Jennifer A, et al.
Publicado: (2019)

Community pharmacists’ acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: Booker, Connor, et al.
Publicado: (2023)

Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California
por: Hunter, Lauren A, et al.
Publicado: (2023)

Low Rates of Lung Cancer Screening Referrals in Patients With Human Immunodeficiency Virus: A Correlational Study
por: Lopez, Wilfredo, et al.
Publicado: (2022)

Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics
por: Saberi, Parya, et al.
Publicado: (2022)

1545 Knowledge, Attitudes and Beliefs Regarding the Potential Impact of Health Care Reform on HIV-Infected Patients
por: Rozin, Irina, et al.
Publicado: (2014)

Is Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin?
por: Kojima, Noah, et al.
Publicado: (2016)

Effectiveness of Noncertified Pharmacist–Led Antimicrobial Stewardship Programs in a Medium-Sized Hospital Without an Infectious Disease Specialist: A Retrospective Pre–Post Study
por: Sawada, Keisuke, et al.
Publicado: (2023)

Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation
por: Wagner, Gabriel A, et al.
Publicado: (2023)

1256. Contemporary Evaluation of Racial/Ethnic Disparities in Survival and Disease Progression among People with HIV in the US Midwest
por: Khazanchi, Rohan, et al.
Publicado: (2019)

Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus
por: Brizzi, Marisa B, et al.
Publicado: (2020)

Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care
por: Kamis, Kevin F, et al.
Publicado: (2019)

Pre-exposure Prophylaxis Recent Adherence With Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial Among Postpartum Women
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2021)

Human Immunodeficiency Virus Pre-Exposure Prophylaxis Knowledge, Attitudes, and Self-Efficacy Among Family Planning Providers in the Southern United States: Bridging the Gap in Provider Training
por: Ramakrishnan, Aditi, et al.
Publicado: (2022)

Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients
por: Hannah, Claire E, et al.
Publicado: (2020)

The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?
por: Scarsi, Kimberly K., et al.
Publicado: (2021)

Implementation and effectiveness of a COVID-19 case investigation and contact tracing program at a large, urban midwestern university
por: Vaughn, Jocelyn, et al.
Publicado: (2023)

A pilot feasibility study of a peer-led mindfulness program for medical students
por: Danilewitz, Marlon, et al.
Publicado: (2016)

Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study
por: Ocieczek, Paulina, et al.
Publicado: (2019)

Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center
por: Marcus, Julia L, et al.
Publicado: (2021)

Am I Positive? Improving Human Immunodeficiency Virus Testing in the Era of Preexposure Prophylaxis and Immediate Antiretroviral Therapy Using Machine Learning
por: Zucker, Jason, et al.
Publicado: (2022)

The Effect of Pharmacist-Led Intervention on Surgical Antibacterial Prophylaxis (SAP) at an Orthopedic Unit
por: Fésüs, Adina, et al.
Publicado: (2021)

A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
por: Bares, Sara H., et al.
Publicado: (2022)

Feasibility and Acceptability of Community Coronavirus Disease 2019 Testing Strategies (FACTS) in a University Setting
por: Hirst, Jennifer A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qg9d1qvpqt07ea1ptna3ksht8